1
                                                                    Exhibit 99.1


                                 ONCORMED, INC.

                    PROXY SOLICITED BY THE BOARD OF DIRECTORS
                      FOR A SPECIAL MEETING OF STOCKHOLDERS
                       TO BE HELD ON _______________, 1998

           The undersigned hereby appoints Dr. Timothy J. Triche and Dr. Douglas
Dolginow, and each of them, as attorneys and proxies of the undersigned, with
full power of substitution, to vote all of the shares of stock of Oncormed, Inc.
("Oncormed") which the undersigned may be entitled to vote at a Special Meeting
of Stockholders of Oncormed. to be held at the offices of Gene Logic at 205
Perry Parkway, Gaithersburg, MD 20877, on __________, __________________, 1998
at 10:00 a.m., local time, and at any and all postponements, continuations and
adjournments thereof (the "Oncormed Special Meeting"), with all powers that the
undersigned would possess if personally present, upon and in respect of the
following matters and in accordance with the following instructions, with
discretionary authority as to any and all other matters that may properly come
before the Oncormed Special Meeting.

           THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER
DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. UNLESS A CONTRARY DIRECTION IS
INDICATED, THIS PROXY WILL BE VOTED FOR PROPOSAL 1, AS MORE SPECIFICALLY
DESCRIBED IN THE NOTICE AND IN THE PROSPECTUS/JOINT PROXY STATEMENT TRANSMITTED
IN CONNECTION WITH THE ONCORMED SPECIAL MEETING. ANY HOLDER WHO WISHES TO
WITHHOLD THE DISCRETIONARY AUTHORITY REFERRED TO IN PROPOSAL 2 BELOW SHOULD MARK
A LINE THROUGH THE ENTIRE PROPOSAL.

MANAGEMENT RECOMMENDS A VOTE FOR PROPOSALS 1 AND 2.


                  
PROPOSAL 1           To (i) approve and adopt the Agreement and Plan of Merger and Reorganization dated as of July 6, 1998 (the
                     "Merger Agreement") among Oncormed, Gene Logic Inc., a Delaware corporation ("Gene Logic") and Gene Logic
                     Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Gene Logic ("Merger Sub"), and (ii)
                     approve the merger of Oncormed with and into Merger Sub (the "Merger"), pursuant to which Oncormed will cease
                     to exist and Merger Sub will be the surviving corporation (the "Merger Proposal").

           [  ]      FOR                    [  ]         AGAINST                      [  ]         ABSTAIN

PROPOSAL 2           In the Board's discretion, to act upon any matters incidental to the foregoing and such other business as may
                     properly come before the Oncormed Special Meeting.


Receipt of the Prospectus/Joint Proxy Statement dated _____________, 1998 is
hereby acknowledged.

Dated ______________, 1998
                                   --------------------------------------

                                   --------------------------------------
                                               SIGNATURE(S)

                Please sign exactly as your name appears hereon. If the
                stock is registered in the names of two or more persons, each
                should sign. Executors, administrators, trustees, guardians and
                attorneys-in-fact should add their titles. If signer is a
                corporation, please give full corporate name and have a duly
                authorized officer sign, stating title. If signer is a
                partnership, please sign in partnership name by an authorized
                person.


PLEASE VOTE, DATE AND PROMPTLY RETURN THIS PROXY IN THE ENCLOSED RETURN ENVELOPE
WHICH IS POSTAGE PREPAID IF MAILED IN THE UNITED STATES.